Clinical outcomes of transoral robotic supraglottic laryngectomy
Adult
Male
Mouth
Operative Time
Laryngectomy
Robotics
Middle Aged
3. Good health
03 medical and health sciences
Treatment Outcome
0302 clinical medicine
Carcinoma, Squamous Cell
Humans
Minimally Invasive Surgical Procedures
Female
Prospective Studies
Laryngeal Neoplasms
Aged
DOI:
10.1002/hed.23101
Publication Date:
2012-08-21T07:21:29Z
AUTHORS (6)
ABSTRACT
AbstractBackgroundTransoral, minimally invasive organ preservation surgeries are being increasingly used for laryngopharyngeal carcinomas to avoid the toxicities of combined chemotherapy and radiation therapy regimens. This study investigates the efficiency, safety, and functional outcomes of transoral robotic surgery (TORS) supraglottic laryngectomy.MethodsPatients with laryngeal cancer who underwent TORS supraglottic laryngectomy and participated in a prospective TORS study between 2008 and 2011 at an academic medical center are presented.ResultsThirteen of 126 patients underwent TORS supraglottic laryngectomy for laryngeal cancer. Average robotic operative time and estimated blood loss were 25.3 minutes and 15.4 mL, respectively. Negative surgical margins were achieved in all patients. Eleven patients were started on an oral diet within 24 hours of surgery with no evidence of immediate airway compromise. Two patients (15.4%) received adjuvant radiation therapy based on pathology.ConclusionIn this preliminary study, TORS supraglottic laryngectomy was a safe procedure with good functional outcomes. © 2012 Wiley Periodicals, Inc. Head Neck, 2013
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (12)
CITATIONS (74)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....